Cargando…
Serum homocysteine and risk of dementia in Japan
OBJECTIVE: To examine the association between serum total homocysteine levels (tHcy) and dementia risk. METHODS: A total of 1588 Japanese adults aged ≥60 years without dementia were prospectively followed from 2002 to 2012. Cox proportional hazards models and restricted cubic splines were used to es...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231445/ https://www.ncbi.nlm.nih.gov/pubmed/32234968 http://dx.doi.org/10.1136/jnnp-2019-322366 |
_version_ | 1783535191671701504 |
---|---|
author | Chen, Sanmei Honda, Takanori Ohara, Tomoyuki Hata, Jun Hirakawa, Yoichiro Yoshida, Daigo Shibata, Mao Sakata, Satoko Oishi, Emi Furuta, Yoshihiko Kitazono, Takanari Ninomiya, Toshiharu |
author_facet | Chen, Sanmei Honda, Takanori Ohara, Tomoyuki Hata, Jun Hirakawa, Yoichiro Yoshida, Daigo Shibata, Mao Sakata, Satoko Oishi, Emi Furuta, Yoshihiko Kitazono, Takanari Ninomiya, Toshiharu |
author_sort | Chen, Sanmei |
collection | PubMed |
description | OBJECTIVE: To examine the association between serum total homocysteine levels (tHcy) and dementia risk. METHODS: A total of 1588 Japanese adults aged ≥60 years without dementia were prospectively followed from 2002 to 2012. Cox proportional hazards models and restricted cubic splines were used to estimate the HRs of tHcy levels on the risk of dementia. RESULTS: During the follow-up, 372 subjects developed all-cause dementia; 247 had Alzheimer’s disease (AD) and 98 had vascular dementia (VaD). Compared with the lowest tHcy quintile (≤6.4 µmol/L), the multivariable-adjusted HRs (95% CI) of the highest quintile (≥11.5 µmol/L) were 2.28 (1.51–3.43) for all-cause dementia, 1.96 (1.19–3.24) for AD and 2.51 (1.14–5.51) for VaD. In restricted cubic splines, the risk of all-cause dementia steadily increased between approximately 8–15 µmol/L and plateaued thereafter, with a similar non-linear shape observed for AD and VaD (all p for non-linearity ≤0.02). In stratified analyses by the most recognised genetic polymorphism affecting tHcy concentrations (methylenetetrahydrofolate reductase C677T), the positive association of tHcy with all-cause dementia persisted in both non-carriers and carriers of the risk allele, and even tended to be stronger in the former (p for heterogeneity=0.07). CONCLUSION: High serum tHcy levels are associated with an elevated risk of dementia, AD and VaD in a non-linear manner, such that an exposure-response association is present only within a relatively high range of tHcy levels. Non-genetic factors affecting serum tHcy concentrations may play important roles in tHcy-dementia associations irrespective of the genetic susceptibility for raised tHcy. |
format | Online Article Text |
id | pubmed-7231445 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-72314452020-05-18 Serum homocysteine and risk of dementia in Japan Chen, Sanmei Honda, Takanori Ohara, Tomoyuki Hata, Jun Hirakawa, Yoichiro Yoshida, Daigo Shibata, Mao Sakata, Satoko Oishi, Emi Furuta, Yoshihiko Kitazono, Takanari Ninomiya, Toshiharu J Neurol Neurosurg Psychiatry Neuropsychiatry OBJECTIVE: To examine the association between serum total homocysteine levels (tHcy) and dementia risk. METHODS: A total of 1588 Japanese adults aged ≥60 years without dementia were prospectively followed from 2002 to 2012. Cox proportional hazards models and restricted cubic splines were used to estimate the HRs of tHcy levels on the risk of dementia. RESULTS: During the follow-up, 372 subjects developed all-cause dementia; 247 had Alzheimer’s disease (AD) and 98 had vascular dementia (VaD). Compared with the lowest tHcy quintile (≤6.4 µmol/L), the multivariable-adjusted HRs (95% CI) of the highest quintile (≥11.5 µmol/L) were 2.28 (1.51–3.43) for all-cause dementia, 1.96 (1.19–3.24) for AD and 2.51 (1.14–5.51) for VaD. In restricted cubic splines, the risk of all-cause dementia steadily increased between approximately 8–15 µmol/L and plateaued thereafter, with a similar non-linear shape observed for AD and VaD (all p for non-linearity ≤0.02). In stratified analyses by the most recognised genetic polymorphism affecting tHcy concentrations (methylenetetrahydrofolate reductase C677T), the positive association of tHcy with all-cause dementia persisted in both non-carriers and carriers of the risk allele, and even tended to be stronger in the former (p for heterogeneity=0.07). CONCLUSION: High serum tHcy levels are associated with an elevated risk of dementia, AD and VaD in a non-linear manner, such that an exposure-response association is present only within a relatively high range of tHcy levels. Non-genetic factors affecting serum tHcy concentrations may play important roles in tHcy-dementia associations irrespective of the genetic susceptibility for raised tHcy. BMJ Publishing Group 2020-05 2020-03-31 /pmc/articles/PMC7231445/ /pubmed/32234968 http://dx.doi.org/10.1136/jnnp-2019-322366 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Neuropsychiatry Chen, Sanmei Honda, Takanori Ohara, Tomoyuki Hata, Jun Hirakawa, Yoichiro Yoshida, Daigo Shibata, Mao Sakata, Satoko Oishi, Emi Furuta, Yoshihiko Kitazono, Takanari Ninomiya, Toshiharu Serum homocysteine and risk of dementia in Japan |
title | Serum homocysteine and risk of dementia in Japan |
title_full | Serum homocysteine and risk of dementia in Japan |
title_fullStr | Serum homocysteine and risk of dementia in Japan |
title_full_unstemmed | Serum homocysteine and risk of dementia in Japan |
title_short | Serum homocysteine and risk of dementia in Japan |
title_sort | serum homocysteine and risk of dementia in japan |
topic | Neuropsychiatry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231445/ https://www.ncbi.nlm.nih.gov/pubmed/32234968 http://dx.doi.org/10.1136/jnnp-2019-322366 |
work_keys_str_mv | AT chensanmei serumhomocysteineandriskofdementiainjapan AT hondatakanori serumhomocysteineandriskofdementiainjapan AT oharatomoyuki serumhomocysteineandriskofdementiainjapan AT hatajun serumhomocysteineandriskofdementiainjapan AT hirakawayoichiro serumhomocysteineandriskofdementiainjapan AT yoshidadaigo serumhomocysteineandriskofdementiainjapan AT shibatamao serumhomocysteineandriskofdementiainjapan AT sakatasatoko serumhomocysteineandriskofdementiainjapan AT oishiemi serumhomocysteineandriskofdementiainjapan AT furutayoshihiko serumhomocysteineandriskofdementiainjapan AT kitazonotakanari serumhomocysteineandriskofdementiainjapan AT ninomiyatoshiharu serumhomocysteineandriskofdementiainjapan |